查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1813262

2032 年幾丁聚醣傷口敷料市場預測：按產品類型、傷口類型、分銷管道、等級、配方、最終用戶和地區進行的全球分析

Chitosan Wound Dressings Market Forecasts to 2032 - Global Analysis By Product Type, Wound Type, Distribution Channel, Grade, Formulation, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球幾丁聚醣傷口敷料市場預計在 2025 年達到 3.9025 億美元，到 2032 年將達到 8.3611 億美元，預測期內的複合年成長率為 11.5%。

幾丁聚醣傷口敷料是一種由殼聚醣製成的先進醫用敷料。幾丁聚醣是一種源自甲殼類動物殼中幾丁質的天然生物聚合物。殼聚醣以其生物相容性、抗菌和止血特性而聞名，有助於控制出血、降低感染風險並維持濕潤的傷口環境，促進更快癒合。這類敷料廣泛用於治療慢性傷口、燒燙傷、手術切口和創傷，提供有效保護並支持組織再生，進而改善復原效果。

根據世界衛生組織 (WHO) 的數據，全球約有 5% 的人口患有慢性傷口，這嚴重影響了醫療成本和生活品質。

慢性傷口增加

在全球範圍內，慢性傷口（包括糖尿病足潰瘍、壓瘡和下肢靜脈潰瘍）的增多，推動了對先進創傷護理解決方案的需求。幾丁聚醣敷料因其天然抗菌特性、生物相容性和支持組織再生的能力而備受關注。奈米纖維支架和生物活性幾丁聚醣複合材料等創新技術改善了傷口癒合效果。雙層敷料和幾丁聚醣水凝膠等新產品也應運而生，以應對複雜的傷口環境。越來越多的醫療保健提供者採用這些敷料來降低感染風險並促進傷口癒合。隨著慢性傷口發生率的上升，幾丁聚醣技術正成為下一代創傷護理策略的核心。

產品壽命短

雖然幾丁聚醣的可生物分解特性使其有利於癒合，但在某些條件下容易分解。研究人員正在探索穩定技術，例如聚合物共混物和先進包裝，以延長其使用壽命。防潮塗層和溫控物流等創新技術有助於降低腐敗風險。保存期限測試的監管要求增加了產品核可和市場准入的複雜性。這些限制因素持續阻礙擴充性和廣泛應用，尤其是在低溫運輸基礎設施有限的地區。

在外科手術和創傷護理的應用日益增多

幾丁聚醣敷料因其快速凝血和控制感染的優勢，在外科手術和創傷護理中的應用日益廣泛。諸如可注射幾丁聚醣凝膠、抗菌泡沫和複合海綿等新型敷料正在開發用於術中和術後。智慧傷口技術將幾丁聚醣與感測器和反應材料結合，以即時監測傷口癒合情況。醫院優先考慮能夠減少併發症並改善患者預後的敷料，尤其是在高風險手術中。監管部門的核准和臨床檢驗正在加速其在整形外科、心血管和急診醫學領域的應用。急性護理領域日益成長的市場佔有率，為幾丁聚醣基產品帶來了巨大的成長機會。

來自替代傷口敷料的競爭

幾丁聚醣傷口敷料正面臨其他先進材料（包括藻酸鹽、親水膠體和合成聚合物）日益激烈的競爭。這些替代材料通常保存期限更長、製造成本更低，並且得到廣泛的臨床認可。混合敷料（包含多種生醫材料）正日益普及，因為它們挑戰了幾丁聚醣單一的價值提案。人工智慧驅動的材料設計和3D列印技術正在推動客製化創傷護理解決方案的快速發展。消費者和臨床醫生的偏好正轉向集癒合、監控和舒適性於一體的多功能敷料。這種競爭壓力正在分化市場，迫使幾丁聚醣製造商透過創新和臨床表現來實現差異化。

COVID-19的影響

新冠疫情擾亂了傷口護理服務，延誤了擇期手術，並限制了高級敷料的取得。然而，它也加速了遠端傷口管理和分散式護理模式的創新，而幾丁聚醣敷料已被證明在這些模式中特別有效。遠端醫療平台使臨床醫生能夠遠端監測創傷治療並調整治療通訊協定。這場危機也提高了人們對感染控制的認知，並激發了人們對幾丁聚醣等抗菌和免疫支持材料的興趣。製造商透過投資本地生產和靈活的供應鏈來滿足需求。

幾丁聚醣膜敷料市場預計將在預測期內佔據最大佔有率

幾丁聚醣膜敷料因其適應性強、使用方便且傷口覆蓋效果出色，預計將在預測期內佔據最大的市場佔有率。這些薄膜能夠保持最佳濕度，促進氧氣交換，並提供抗菌保護，這些對於有效癒合至關重要。創新技術包括嵌入治療劑的多層薄膜和用於傷口監測的智慧感測器。人們對兼具舒適性和臨床有效性的敷料的需求日益成長，尤其是在術後和慢性傷口護理。醫院和診所更青睞便利且經過驗證的薄膜敷料。監管發展和臨床試驗持續鞏固了主導地位。

預計家庭醫療保健領域在預測期內將實現最高複合年成長率

預計家庭醫療保健領域將在預測期內實現最高成長率，這得益於慢性傷口的增加、人口老化以及對經濟實惠的自我管理護理解決方案的需求。水凝膠基幾丁聚醣層和奈米增強抗菌敷料等創新技術正在提高治療效果和使用者便利性。值得關注的趨勢包括客製化傷口護理以及針對糖尿病和壓力相關傷口的生物活性混合物。近期在分層複合材料設計和智慧包裝方面的突破實現了遠端監控，使居家創傷護理更加實用且更具可擴展性。

比最大的地區

由於慢性傷口數量的增加以及對生物相容性天然材料的日益偏好，預計亞太地區將在預測期內佔據最大的市場佔有率。幾丁聚醣基水凝膠、抗菌膜和先進敷料等技術創新正在改善傷口癒合效果。值得關注的趨勢包括可生物分解解決方案以及與智慧創傷護理技術的整合。研發活動的活性化、生物基產品的優惠監管政策以及旨在擴大生產和實現液體、粉末和黏合劑應用多樣化的策略夥伴關係關係，進一步塑造了市場。

複合年成長率最高的地區：

預計北美將在預測期內實現最高的複合年成長率，這得益於慢性傷口的增加、人們對生物活性癒合劑日益成長的興趣，以及監管機構對生物相容性解決方案的大力支持。技術進步正在推動水凝膠、抗菌層和奈米複合材料敷料的發展。個人化治療方法和基於生物感測器的傷口監測正日益普及。該行業的關鍵促進因素包括再生療法資金籌措的活性化、下一代製劑的監管核准，以及Primex和NovaMatrix等公司為擴大其環保植物來源幾丁聚醣產品而做出的努力。

免費客製化服務：

此報告的訂閱者可以選擇以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球幾丁聚醣傷口敷料市場（依產品類型）

  • 幾丁聚醣水凝膠敷料
  • 幾丁聚醣膜敷料
  • 幾丁聚醣粉液敷料
  • 幾丁聚醣海綿敷料
  • 複合敷料
  • 其他產品類型

6. 全球幾丁聚醣傷口敷料市場（依傷口類型）

  • 慢性傷口
    • 糖尿病潰瘍
    • 靜脈性腿部潰瘍
    • 壓瘡
  • 急性傷口
    • 手術傷口
    • 創傷
    • 燒燙傷

7. 全球幾丁聚醣傷口敷料市場（依通路）

  • 直銷
  • 藥局
  • 線上零售商
  • 超級市場/大賣場

8. 全球幾丁聚醣傷口敷料市場（依等級）

  • 海洋貝類
  • 不含動物成分的幾丁聚醣
  • 醫療級
  • 消費級

9. 全球幾丁聚醣傷口敷料市場（依配方）

  • 抗菌強化
  • 吸水性強
  • 重視止血
  • 生物活性

第 10 章全球幾丁聚醣傷口敷料市場（依最終用戶）

  • 醫院和診所
  • 家庭醫療保健
  • 門診手術中心
  • 護理設施
  • 其他最終用戶

第11章全球幾丁聚醣傷口敷料市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章：企業概況

  • Smith+Nephew
  • Tuoren Medical
  • 3M Health Care
  • BenQ Materials Corp.
  • Coloplast
  • Humanwell Healthcare
  • ConvaTec Group
  • Axio Biosolutions
  • Medline Industries
  • Guangxi Xinye Biotechnology
  • B. Braun Melsungen AG
  • Zhejiang Dingtai Pharmaceutical
  • Molnlycke Health Care
  • Wuhan Dazheng Hi-Tech Biomedical
  • Suzhou Meida Medical Instrument
Product Code: SMRC30721

According to Stratistics MRC, the Global Chitosan Wound Dressings Market is accounted for $390.25 million in 2025 and is expected to reach $836.11 million by 2032 growing at a CAGR of 11.5% during the forecast period. Chitosan wound dressings are advanced medical dressings made from chitosan, a natural biopolymer derived from chitin found in crustacean shells. Known for their biocompatibility, antibacterial action, and hemostatic properties, they promote faster healing by controlling bleeding, reducing infection risks, and maintaining a moist wound environment. These dressings are widely used for treating chronic wounds, burns, surgical cuts, and trauma injuries, offering effective protection and supporting tissue regeneration for improved recovery outcomes.

According to the World Health Organization, approximately 5% of the global population suffers from chronic wounds, which significantly contributes to healthcare costs and impacts the quality of life.

Market Dynamics:

Driver:

Rising prevalence of chronic wounds

The global rise in chronic wounds such as diabetic foot ulcers, pressure injuries, and venous leg ulcers is fueling demand for advanced wound care solutions. Chitosan-based dressings are gaining prominence due to their natural antimicrobial properties, biocompatibility, and ability to support tissue regeneration. Innovations like nanofiber scaffolds and bioactive chitosan composites are improving healing outcomes. New product formats are emerging, including dual-layer dressings and chitosan-infused hydrogels, tailored for complex wound environments. Healthcare providers are increasingly adopting these dressings to reduce infection risk and accelerate recovery. As chronic wound prevalence climbs, chitosan technologies are becoming central to next-generation wound care strategies.

Restraint:

Short shelf life of products

The biodegradable nature of chitosan, while beneficial for healing, makes it vulnerable to degradation under certain conditions. Researchers are exploring stabilization techniques such as polymer blending and advanced packaging to extend usability. Innovations like moisture-resistant coatings and temperature-controlled logistics are helping mitigate spoilage risks. Regulatory requirements around shelf-life testing add complexity to product approvals and market entry. These limitations continue to hinder scalability and broader adoption, especially in regions with limited cold-chain infrastructure.

Opportunity:

Rising adoption in surgical and trauma care

Chitosan dressings are increasingly being used in surgical and trauma care due to their rapid clotting ability and infection control benefits. New formats such as injectable chitosan gels, antimicrobial foams, and composite sponges are being developed for intraoperative and post-surgical applications. Smart wound technologies are integrating chitosan with sensors and responsive materials to monitor healing in real time. Hospitals are prioritizing dressings that reduce complications and improve patient outcomes, especially in high-risk procedures. Regulatory approvals and clinical validations are accelerating adoption in orthopedic, cardiovascular, and emergency care. This growing footprint in acute care settings presents a major growth opportunity for chitosan-based products.

Threat:

Competition from alternative wound dressing materials

The chitosan wound dressing is facing growing competition from other advanced materials such as alginates, hydrocolloids, and synthetic polymers. These alternatives often offer longer shelf life, lower production costs, and broader clinical familiarity. Hybrid dressings combining multiple biomaterials are gaining traction, challenging chitosan's standalone value proposition. AI-driven material design and 3D printing are enabling rapid development of customized wound care solutions. Consumer and clinical preferences are shifting toward multifunctional dressings that combine healing, monitoring, and comfort. This competitive pressure is fragmenting the market and forcing chitosan manufacturers to differentiate through innovation and clinical performance.

Covid-19 Impact

The Covid-19 pandemic disrupted wound care services, delaying elective procedures and limiting access to advanced dressings. However, it also accelerated innovation in remote wound management and decentralized care models, where chitosan dressings proved especially useful. Telemedicine platforms enabled clinicians to monitor wound healing and adjust treatment protocols from a distance. The crisis heightened awareness of infection control, boosting interest in antimicrobial and immune-supportive materials like chitosan. Manufacturers responded by investing in local production and flexible supply chains to meet demand.

The chitosan film dressings segment is expected to be the largest during the forecast period

The chitosan film dressings segment is expected to account for the largest market share during the forecast period, due to their adaptability, ease of use, and superior wound coverage. These films maintain optimal moisture levels, support oxygen exchange, and offer antimicrobial protection key factors for effective healing. Innovations include multilayer films with embedded therapeutics and smart sensors for wound monitoring. Demand is rising for dressings that combine comfort with clinical efficacy, especially in post-operative and chronic wound care. Hospitals and clinics favour film formats for their simplicity and proven outcomes. Regulatory endorsements and clinical trials continue to reinforce their leadership position in the wound dressing landscape.

The home healthcare segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate, fuelled by increasing chronic wound prevalence, aging demographics, and the need for affordable, self-managed care solutions. Innovations like hydrogel-based chitosan layers and nano-enhanced antimicrobial dressings are boosting treatment efficacy and user convenience. Notable trends include customized wound therapies and bioactive blends for diabetic and pressure-related wounds. Recent breakthroughs feature layered composite designs and smart-enabled packaging, enabling remote monitoring and making home-based wound care more practical and scalable.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising incidences of chronic wounds and increasing preference for biocompatible, natural materials. Innovations in chitosan-based hydrogels, antimicrobial films, and advanced dressing formats are improving healing performance. Notable trends include biodegradable solutions and integration with smart wound care technologies. The market is further shaped by growing R&D activity, favourable regulatory policies for bio-based products, and strategic partnerships aimed at scaling production and diversifying applications across liquid, powder, and adhesive formats.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by a growing incidence of chronic wounds, rising interest in bioactive healing agents, and strong regulatory endorsement for biocompatible solutions. Advances in technology are driving the development of hydrogels, antimicrobial layers, and nanocomposite-based dressings. Personalized treatment approaches and biosensor-enabled wound monitoring are gaining traction. Key industry moves include heightened funding in regenerative therapies, regulatory approvals for next-gen formulations, and expansion efforts by firms like Primex and NovaMatrix to scale eco-friendly, plant-derived chitosan offerings.

Key players in the market

Some of the key players profiled in the Chitosan Wound Dressings Market include Smith+Nephew, Tuoren Medical, 3M Health Care, BenQ Materials Corp., Coloplast, Humanwell Healthcare, ConvaTec Group, Axio Biosolutions, Medline Industries, Guangxi Xinye Biotechnology, B. Braun Melsungen AG, Zhejiang Dingtai Pharmaceutical, Molnlycke Health Care, Wuhan Dazheng Hi-Tech Biomedical, and Suzhou Meida Medical Instrument.

Key Developments:

In March 2025, Convatec announced its global collaboration with the Wound, Ostomy, and Continence Nurses Society(TM) (WOCN(R)), the largest and most recognised professional nursing community dedicated to advancing the practice and delivery of expert healthcare to individuals with wound, ostomy, and continence care needs.

In December 2024, Smith+Nephew announces its CORIOGRAPH Pre-Op Planning and Modeling Services is now cleared for total hip arthroplasty (THA) by the United States Food and Drug Administration. Exclusively for users of the CORI Surgical System, this innovative planning software allows for use of either X-rays or CT scans for planning and modeling, enabling surgeons to make a patient-specific plan for the best possible outcome.

Product Types Covered:

  • Chitosan Hydrogel Dressings
  • Chitosan Film Dressings
  • Chitosan Powder & Liquid Dressings
  • Chitosan Sponge Dressings
  • Composite Dressings
  • Other Product Types

Wound Types Covered:

  • Chronic Wounds
  • Acute Wounds

Distribution Channels Covered:

  • Direct Sales
  • Pharmacies
  • Online Retailers
  • Supermarkets/Hypermarkets

Grades Covered:

  • Marine Shellfish
  • Non-animal Chitosan
  • Medical Grades
  • Consumer Grade

Formulations Covered:

  • Antimicrobial-Enhanced
  • High Absorbency
  • Hemostatic-Focused
  • Bioactive

End Users Covered:

  • Hospitals & Clinics
  • Home Healthcare
  • Ambulatory Surgical Centers
  • Nursing Homes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Chitosan Wound Dressings Market, By Product Type

  • 5.1 Introduction
  • 5.2 Chitosan Hydrogel Dressings
  • 5.3 Chitosan Film Dressings
  • 5.4 Chitosan Powder & Liquid Dressings
  • 5.5 Chitosan Sponge Dressings
  • 5.6 Composite Dressings
  • 5.7 Other Product Types

6 Global Chitosan Wound Dressings Market, By Wound Type

  • 6.1 Introduction
  • 6.2 Chronic Wounds
    • 6.2.1 Diabetic Ulcers
    • 6.2.2 Venous Leg Ulcers
    • 6.2.3 Pressure Ulcers
  • 6.3 Acute Wounds
    • 6.3.1 Surgical Wounds
    • 6.3.2 Traumatic Injuries
    • 6.3.3 Burns

7 Global Chitosan Wound Dressings Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct Sales
  • 7.3 Pharmacies
  • 7.4 Online Retailers
  • 7.5 Supermarkets/Hypermarkets

8 Global Chitosan Wound Dressings Market, By Grade

  • 8.1 Introduction
  • 8.2 Marine Shellfish
  • 8.3 Non-animal Chitosan
  • 8.4 Medical Grades
  • 8.5 Consumer Grade

9 Global Chitosan Wound Dressings Market, By Formulation

  • 9.1 Introduction
  • 9.2 Antimicrobial-Enhanced
  • 9.3 High Absorbency
  • 9.4 Hemostatic-Focused
  • 9.5 Bioactive

10 Global Chitosan Wound Dressings Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals & Clinics
  • 10.3 Home Healthcare
  • 10.4 Ambulatory Surgical Centers
  • 10.5 Nursing Homes
  • 10.6 Other End Users

11 Global Chitosan Wound Dressings Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Smith+Nephew
  • 13.2 Tuoren Medical
  • 13.3 3M Health Care
  • 13.4 BenQ Materials Corp.
  • 13.5 Coloplast
  • 13.6 Humanwell Healthcare
  • 13.7 ConvaTec Group
  • 13.8 Axio Biosolutions
  • 13.9 Medline Industries
  • 13.10 Guangxi Xinye Biotechnology
  • 13.11 B. Braun Melsungen AG
  • 13.12 Zhejiang Dingtai Pharmaceutical
  • 13.13 Molnlycke Health Care
  • 13.14 Wuhan Dazheng Hi-Tech Biomedical
  • 13.15 Suzhou Meida Medical Instrument

List of Tables

  • Table 1 Global Chitosan Wound Dressings Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Chitosan Wound Dressings Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Chitosan Wound Dressings Market Outlook, By Chitosan Hydrogel Dressings (2024-2032) ($MN)
  • Table 4 Global Chitosan Wound Dressings Market Outlook, By Chitosan Film Dressings (2024-2032) ($MN)
  • Table 5 Global Chitosan Wound Dressings Market Outlook, By Chitosan Powder & Liquid Dressings (2024-2032) ($MN)
  • Table 6 Global Chitosan Wound Dressings Market Outlook, By Chitosan Sponge Dressings (2024-2032) ($MN)
  • Table 7 Global Chitosan Wound Dressings Market Outlook, By Composite Dressings (2024-2032) ($MN)
  • Table 8 Global Chitosan Wound Dressings Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 9 Global Chitosan Wound Dressings Market Outlook, By Wound Type (2024-2032) ($MN)
  • Table 10 Global Chitosan Wound Dressings Market Outlook, By Chronic Wounds (2024-2032) ($MN)
  • Table 11 Global Chitosan Wound Dressings Market Outlook, By Diabetic Ulcers (2024-2032) ($MN)
  • Table 12 Global Chitosan Wound Dressings Market Outlook, By Venous Leg Ulcers (2024-2032) ($MN)
  • Table 13 Global Chitosan Wound Dressings Market Outlook, By Pressure Ulcers (2024-2032) ($MN)
  • Table 14 Global Chitosan Wound Dressings Market Outlook, By Acute Wounds (2024-2032) ($MN)
  • Table 15 Global Chitosan Wound Dressings Market Outlook, By Surgical Wounds (2024-2032) ($MN)
  • Table 16 Global Chitosan Wound Dressings Market Outlook, By Traumatic Injuries (2024-2032) ($MN)
  • Table 17 Global Chitosan Wound Dressings Market Outlook, By Burns (2024-2032) ($MN)
  • Table 18 Global Chitosan Wound Dressings Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 19 Global Chitosan Wound Dressings Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 20 Global Chitosan Wound Dressings Market Outlook, By Pharmacies (2024-2032) ($MN)
  • Table 21 Global Chitosan Wound Dressings Market Outlook, By Online Retailers (2024-2032) ($MN)
  • Table 22 Global Chitosan Wound Dressings Market Outlook, By Supermarkets/Hypermarkets (2024-2032) ($MN)
  • Table 23 Global Chitosan Wound Dressings Market Outlook, By Grade (2024-2032) ($MN)
  • Table 24 Global Chitosan Wound Dressings Market Outlook, By Marine Shellfish (2024-2032) ($MN)
  • Table 25 Global Chitosan Wound Dressings Market Outlook, By Non-animal Chitosan (2024-2032) ($MN)
  • Table 26 Global Chitosan Wound Dressings Market Outlook, By Medical Grades (2024-2032) ($MN)
  • Table 27 Global Chitosan Wound Dressings Market Outlook, By Consumer Grade (2024-2032) ($MN)
  • Table 28 Global Chitosan Wound Dressings Market Outlook, By Formulation (2024-2032) ($MN)
  • Table 29 Global Chitosan Wound Dressings Market Outlook, By Antimicrobial-Enhanced (2024-2032) ($MN)
  • Table 30 Global Chitosan Wound Dressings Market Outlook, By High Absorbency (2024-2032) ($MN)
  • Table 31 Global Chitosan Wound Dressings Market Outlook, By Hemostatic-Focused (2024-2032) ($MN)
  • Table 32 Global Chitosan Wound Dressings Market Outlook, By Bioactive (2024-2032) ($MN)
  • Table 33 Global Chitosan Wound Dressings Market Outlook, By End User (2024-2032) ($MN)
  • Table 34 Global Chitosan Wound Dressings Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 35 Global Chitosan Wound Dressings Market Outlook, By Home Healthcare (2024-2032) ($MN)
  • Table 36 Global Chitosan Wound Dressings Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 37 Global Chitosan Wound Dressings Market Outlook, By Nursing Homes (2024-2032) ($MN)
  • Table 38 Global Chitosan Wound Dressings Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.